Category Archives: Clinical Studies

Important invitation by NIH to participate in “Discovery of Biomarkers to Develop Transformational Non-Addictive Therapeutics for Pain”

Posted on August 8, 2018 by hprdsadmin

Workshop at Marriott Wardman-Park, Washington, DC – November 14-15, 2018 with Participants from NIH, NINDS, FDA, Academia and Pharma

Posted in Clinical Studies, Development/ Invention | Comments Off on Important invitation by NIH to participate in “Discovery of Biomarkers to Develop Transformational Non-Addictive Therapeutics for Pain”

A Phase I, randomized, double-blind, laser evoked potential study to evaluate the analgesic/anti-hyperalgesic effect of ASP9226, a state-dependent N-type voltage-gated calcium channel inhibitor, in healthy male subjects

Posted on December 20, 2017 by hprdsadmin

K. Schaffler, A. Fakhoury, W. He, P. Passier, K. Tracy, J. Paul in print, Pain Medicine, DOI:10.1093/pm/pnx338

Posted in Clinical Studies | Comments Off on A Phase I, randomized, double-blind, laser evoked potential study to evaluate the analgesic/anti-hyperalgesic effect of ASP9226, a state-dependent N-type voltage-gated calcium channel inhibitor, in healthy male subjects

A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects

Posted on December 20, 2017 by hprdsadmin

Klaus Schaffler, MD, Ashraf Yassen, PhD, PharmD, Peter Reeh, MD, PhD, and Paul Passier, PhD ASP8477 Paper_FAAH_LEP_Caps Pain Medicine Dec 2017   DOI:10.1093/pm/pnx281

Posted in Clinical Studies | Comments Off on A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects

Investigation of the predictive validity of laser- EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers

Posted on December 20, 2017 by hprdsadmin

BCJP_Pred.Validity_LEP_03.2017_T1 Klaus Schaffler, Laurent B. Nicolas, Andreas Borta, Tobias Brand, Peter Reitmeir, Robert Roebling and Joachim Scholpp in Br J Clin Pharmacol (Jan 2017) DOI:10.1111/bcp.13247 Abstract: AIMS The aim of the present study was to assess the predictivity of laser-(radiant-heat)-evoked … Continue reading →

Posted in Clinical Studies | Comments Off on Investigation of the predictive validity of laser- EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers

HPR Poster Presentation at the 15th World Congress on Pain in Buenos Aires 2014

Posted on June 30, 2014 by Klaus Schaffler

First Clinical Translation of the Anti-Nociceptive/Anti-Hyperalgesic Efficacy of a T-Type Calcium Channel Modulator (Z944) – Using Laser Evoked Potentials and VAS in UV-B and Capsaicin Irritated Skin in Healthy Humans K. D. Schaffler Germany,Head, HPR-Human Pharmacodynamic Res., Munich; M. S. … Continue reading →

Posted in Clinical Studies | Comments Off on HPR Poster Presentation at the 15th World Congress on Pain in Buenos Aires 2014

HPR Dr. Schaffler GmbH in cooperation with Zalicus announces positive results of Z944 Phase 1B Clinical Study in Pain

Posted on June 30, 2014 by Klaus Schaffler

Positive results of Z944 Phase 1B Clinical Study in Pain Efficacy Signals in Inflammatory and Neuropathic Pain Observed Second U.S. Patent Issues for Z944 Providing Exclusivity to 2029 Munich, Germany – June 17th, 2014 – HPR Dr. Schaffler GmbH, a … Continue reading →

Posted in Clinical Studies | Comments Off on HPR Dr. Schaffler GmbH in cooperation with Zalicus announces positive results of Z944 Phase 1B Clinical Study in Pain

An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin

Posted on July 20, 2012 by Klaus Schaffler

Schaffler K, Reeh P, Duan WR, Best AE, Othman AA, Faltynek CR, Locke C, Nothaft W. Br J Clin Pharmacol. 75:2 / 404–414 2012 Jul 10.2012 DOI: 10.1111/j.1365-2125.2012.04377.x. Abstract AIMS: Laser (radiant-heat) evoked potentials (LEPs) from vertex-EEG Peak-to-Peak (PtP) amplitude were … Continue reading →

Posted in Clinical Studies | Comments Off on An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin

Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjects

Posted on July 10, 2012 by Klaus Schaffler

Eef Hoeben, Johan W. Smit, David Upmalis, Sarah Rusch, Klaus Schaffler, Peter Reitmeir, Bernhard Mangold    http://dx.doi.org/10.1016/j.pain.2012.04.018 in PAIN 153 (2012) 1648–1656 (full paper here:) Abstract: The aim of the study was to evaluate the analgesic/antihyperalgesic efficacy and to establish the … Continue reading →

Posted in Clinical Studies | Comments Off on Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjects

HPR Dr. Schaffler GmbH Corporate Video…

Posted on June 10, 2012 by Klaus Schaffler
Posted in Clinical Studies | Comments Off on HPR Dr. Schaffler GmbH Corporate Video…

American Society for Clinical Pharmacology and Therapeutics 2012 ASCPT Annual Meeting, March 12-17, 2012 in National Harbor, Maryland, US

Posted on March 20, 2012 by Klaus Schaffler

We (Andrea Edginton and Klaus Schaffler) had a poster presentation – (in cooperation between School of Pharmacy, University of Waterloo, Ontario, Canada and HPR Munich) at the 2012 ASCPT/ American Society for Clinical Pharmacology and Therapeutics Annual Meeting, March 12-17, … Continue reading →

Posted in Clinical Studies | Comments Off on American Society for Clinical Pharmacology and Therapeutics 2012 ASCPT Annual Meeting, March 12-17, 2012 in National Harbor, Maryland, US